Cargando…

P1532: CLINICAL OUTCOMES OF COVID-19 IN MYCOSIS FUNGOIDES AND SEZARY SYNDROME (MF/SS)

Detalles Bibliográficos
Autores principales:	Levy, Ilana, Rokach, Lior, Melamed, Guy, Alapi, Hilel, Gazit, Sivan, Patalon, Tal, Tadmor, Tamar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430223/ http://dx.doi.org/10.1097/01.HS9.0000973004.96550.ad

Ejemplares similares

P652: IMPROVED SURVIVAL OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA BETWEEN 1998-2022, INCLUDING THE ERA OF TARGET THERAPIES WITH BCL2 AND BTK INHIBITORS.
por: Tadmor, Tamar, et al.
Publicado: (2023)

Pregnancy Course of 10 Women Diagnosed with Chronic Lymphocytic Leukemia
por: Tadmor, Tamar, et al.
Publicado: (2023)

Effectiveness of nirmatrelvir plus ritonavir treatment for patients with chronic lymphocytic leukemia during the Omicron surge
por: Tadmor, Tamar, et al.
Publicado: (2023)

Mycosis fungoides and Sézary syndrome
por: Jonak, Constanze, et al.
Publicado: (2021)

Mycosis fungoides and Sézary syndrome
por: Lee, Hyewon
Publicado: (2023)

The utility of bexarotene in mycosis fungoides and Sézary syndrome
por: Panchal, Manisha R, et al.
Publicado: (2015)

TOX Expression in Mycosis Fungoides and Sezary Syndrome
por: Pileri, Alessandro, et al.
Publicado: (2022)

The Role of Tumor Microenvironment in Mycosis Fungoides and Sézary Syndrome
por: Liu, Zhaorui, et al.
Publicado: (2021)

Mycosis Fungoides and Sézary Syndrome: Microenvironment and Cancer Progression
por: Dobos, Gabor, et al.
Publicado: (2023)

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR MYCOSIS FUNGOIDES AND SEZARY SYNDROME
por: Lechowicz, Mary Jo, et al.
Publicado: (2014)

Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis
por: Vural, Seçil, et al.
Publicado: (2018)

Acute progression of the leukemic phase in mycosis fungoides and Sézary syndrome
por: Maredia, Hasina, et al.
Publicado: (2021)

Mycosis fungoides and Sézary syndrome: focus on the current treatment scenario()()
por: Sanches, José Antonio, et al.
Publicado: (2021)

Mycosis fungoides and Sézary syndrome: clinical, histopathological and immunohistochemical review and update()
por: Yamashita, Thamy, et al.
Publicado: (2012)

Novel and Future Therapeutic Drugs for Advanced Mycosis Fungoides and Sézary Syndrome
por: Oka, Tomonori, et al.
Publicado: (2019)

A rare association of bullous pemphigoid with mycosis fungoides and Sézary syndrome
por: Egger, Andjela, et al.
Publicado: (2020)

Incidence of mycosis fungoides and Sézary syndrome in the Netherlands between 2000 and 2020
por: Ottevanger, R., et al.
Publicado: (2021)

The incidences of other primary cancers in patients with mycosis fungoides and Sézary syndrome
por: Błażewicz, Izabela, et al.
Publicado: (2021)

Expression of Thymidine Phosphorylase in Lymph Nodes Involved with Mycosis Fungoides and Sézary Syndrome
por: Nie, Xingcao, et al.
Publicado: (2011)

The Microenvironment’s Role in Mycosis Fungoides and Sézary Syndrome: From Progression to Therapeutic Implications
por: Pileri, Alessandro, et al.
Publicado: (2021)

Roles of OX40 and OX40 Ligand in Mycosis Fungoides and Sézary Syndrome
por: Kawana, Yuki, et al.
Publicado: (2021)

Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management
por: Miyashiro, Denis, et al.
Publicado: (2023)

Denileukin diftitox for the treatment of CD25 low-expression mycosis fungoides and Sézary syndrome
por: Prince, H. Miles, et al.
Publicado: (2013)

The Treatment of Advanced-Stage Mycosis Fungoides and Sezary Syndrome: a Hematologist’s Point of View
por: Giordano, Antonio, et al.
Publicado: (2022)

Mycosis Fungoides and Sézary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted Therapy
por: García-Díaz, Nuria, et al.
Publicado: (2021)

Quality of life in patients with Mycosis Fungoides and Sézary Syndrome: a systematic review of the literature
por: Ottevanger, R., et al.
Publicado: (2021)

Impact of blood involvement on efficacy and time to response with mogamulizumab in mycosis fungoides and Sézary syndrome
por: Beylot‐Barry, Marie, et al.
Publicado: (2022)

PB2345: MOGAMULIZUMAB IN MYCOSIS FUNGOIDES AND SÈZARY SYNDROME: AN ITALIAN SINGLE CENTER EXPERIENCE
por: Simula, Maria Pina, et al.
Publicado: (2023)

Itchy Skin: A Challenging Differential Diagnosis Between Mycosis Fungoides and Sézary Syndrome
por: Abreu Rocha, Cláudia, et al.
Publicado: (2023)

Photodynamic Therapy with the Silicon Phthalocyanine Pc 4 Induces Apoptosis in Mycosis Fungoides and Sezary Syndrome
por: Lam, Minh, et al.
Publicado: (2010)

Benefit/risk Ratio of Low-dose Methotrexate in Cutaneous Lesions of Mycosis Fungoides and Sézary Syndrome
por: ALENEZI, Fawaz, et al.
Publicado: (2021)

Cost–utility analysis of mogamulizumab in advanced mycosis fungoides and Sézary syndrome cutaneous T-cell lymphoma
por: Muszbek, Noemi, et al.
Publicado: (2023)

What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?
por: Akilov, Oleg E.
Publicado: (2023)

Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors
por: Quadri, Iman, et al.
Publicado: (2023)

Mpox Infection in a Developed Country: A Case Report
por: Patalon, Tal, et al.
Publicado: (2022)

Perspectives on and Quality of Life in Skin of Color Patients With Mycosis Fungoides/Sézary Syndrome: A Qualitative Analysis
por: Abraham, Jaclyn, et al.
Publicado: (2023)

PB2265: RISK FACTORS FOR DISEASE PROGRESSION OF MYCOSIS FUNGOIDES AND SÉZARY SYNDROME IN EAST ASIAN POPULATION
por: Wu, Huai-Chueh Gem, et al.
Publicado: (2023)

Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): focus on chlormethine gel
por: Denis, Daphné, et al.
Publicado: (2019)

Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument
por: McCaffrey, Stacey, et al.
Publicado: (2019)

Low-Dose Total Skin Electron Beam Therapy Combined With Mogamulizumab for Refractory Mycosis Fungoides and Sézary Syndrome
por: Fong, Sophia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7k71dsqk1oi6382mrdokc5228i